PLx Pharma, Inc. (PLXP): Price and Financial Metrics

PLx Pharma, Inc. (PLXP): $0.02

0.00 (0.00%)

POWR Rating

Component Grades








Add PLXP to Watchlist
Sign Up

Industry: Biotech




#279 of 380

in industry

PLXP Price/Volume Stats

Current price $0.02 52-week high $0.04
Prev. close $0.00 52-week low $0.02
Day low $0.02 Volume 4,322,000
Day high $0.04 Avg. volume 0
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 603.16K

PLXP Stock Price Chart Interactive Chart >

PLx Pharma, Inc. (PLXP) Company Bio

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company developing aspirin products that use its patented drug delivery system, which targets delivery of APIs to various portions of the gastrointestinal tract. This has the potential to improve the absorption of many drugs and to reduce acute GI side effects associated with aspirin and ibuprofen, and potentially other drugs.

PLXP Latest News Stream

Event/Time News Detail
Loading, please wait...

PLXP Latest Social Stream

Loading social stream, please wait...

View Full PLXP Social Stream

Latest PLXP News From Around the Web

Below are the latest news stories about PLX PHARMA INC that investors may wish to consider to help them evaluate PLXP as an investment opportunity.

SHOP Stock Price Prediction: Is Shopify Really Worth $65?

Shopify (SHOP) stock is on the move Wednesday following a price target and new rating from JP Morgan analyst Andrew Boone.

William White on InvestorPlace | April 12, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning.

William White on InvestorPlace | April 12, 2023

Why Is National CineMedia (NCMI) Stock Up 75% Today?

National CineMedia (NCMI) stock is on a wild ride Wednesday morning as investors react to restructuring news and a bankruptcy filing.

William White on InvestorPlace | April 12, 2023

Why Is PLx Pharma (PLXP) Stock Down 32% Today?

PLx Pharma (PLXP) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange.

William White on InvestorPlace | April 12, 2023

PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets

SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses. The Company today announced that it entered into a stalking horse asset purchase agreement (the “APA”) with PLx Acquisition Company, LLC, a wholly-owned subsidiary

Yahoo | April 12, 2023

Read More 'PLXP' Stories Here

PLXP Price Returns

1-mo N/A
3-mo N/A
6-mo -80.97%
1-year -96.91%
3-year -99.38%
5-year -99.52%
YTD -87.81%
2022 -97.95%
2021 45.11%
2020 26.32%
2019 185.62%
2018 -77.83%

Continue Researching PLXP

Want to see what other sources are saying about PLx Pharma Inc's financials and stock price? Try the links below:

PLx Pharma Inc (PLXP) Stock Price | Nasdaq
PLx Pharma Inc (PLXP) Stock Quote, History and News - Yahoo Finance
PLx Pharma Inc (PLXP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!